助力国内外作者成功发表NatureScience等国际顶尖期刊!

投稿难?全流程投稿协助,直达Accept!

CSSCICSCD北大统计源知网万方维普

专注期刊投稿咨询

多年服务铸就口碑期刊服务信赖之选
免费咨询

大类学科: 不限 医学 生物 物理 化学 农林科学 数学 地学天文 地学 环境科学与生态学 综合性期刊 管理科学 社会科学 查看全部热门领域

中科院分区: 不限 1区 2区 3区 4区

期刊收录: 不限 SCI SCIE

Frontiers in Bioengineering and Biotechnology

SCI期刊查询网 更新时间:2026-04-02 01:04:37
Frontiers in Bioengineering and Biotechnology封面

简称:FRONT BIOENG BIOTECH

ISSN:2296-4185

ESSN:2296-4185

所属分区:1区

出版地:Switzerland

研究方向:Chemical Engineering-Bioengineering

易录用期刊推荐+论文格式模板+论文快速过审指导

填写需求
联系方式
PS:专业学术顾问会及时联系解答。

Frontiers in Bioengineering and Biotechnology英文简介

The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs.

In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.

IF值(影响因子)趋势图